Works matching IS 03065251 AND DT 2023 AND VI 89 AND IP 8

Results: 37

Issue Highlights.

Published in:: British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2337, doi. 10.1111/bcp.15848
Publication type:: Article

European Medicines Agency seeks stakeholders' views on future transparency measures for clinical trials.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2338, doi. 10.1111/bcp.15825

By:

Gonzalez‐Quevedo, Rosa;
Pioppo, Laura;
Garcia Burgos, Juan;
Arlett, Peter

Publication type:

Article

Azathioprine‐induced vanishing bile duct syndrome: The value of early thiopurine metabolism assessment.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2625, doi. 10.1111/bcp.15797

By:

Chouchana, Laurent;
Terris, Benoit;
Sogni, Philippe;
Treluyer, Jean‐Marc;
Costedoat‐Chalumeau, Nathalie;
Loriot, Marie‐Anne

Publication type:

Article

Improving the spontaneous reporting of suspected adverse drug reactions: An overview of systematic reviews.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2377, doi. 10.1111/bcp.15791

By:

Routledge, Philip Alexander;
Bracchi, Robert

Publication type:

Article

EMA commentary on the ICH guideline for testing for carcinogenicity of pharmaceuticals.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2341, doi. 10.1111/bcp.15790

By:

van der Laan, Jan Willem;
Andersson, Mikael;
Beken, Sonja;
Bonelli, Milton;
Brendler‐Schwaab, Susanne;
Kane, Rosemary;
Pasanen, Markku;
Ponzano, Stefano;
Paur, Jakob;
Siezen, Christine;
Soleng, Anne;
Whomsley, Rhys

Publication type:

Article

Pharmacokinetic drug–drug interactions with direct anticoagulants in the management of cancer‐associated thrombosis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2369, doi. 10.1111/bcp.15785

By:

Van der Linden, Lorenz;
Vanassche, Thomas;
Van Cutsem, Eric;
Van Aelst, Lucas;
Verhamme, Peter

Publication type:

Article

Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2365, doi. 10.1111/bcp.15780

By:

Raschi, Emanuel;
Poluzzi, Elisabetta;
De Ponti, Fabrizio

Publication type:

Article

The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in Europe.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2349, doi. 10.1111/bcp.15779

By:

Mattsson, Molly;
Boland, Fiona;
Kirke, Ciara;
Flood, Michelle;
Wallace, Emma;
Walsh, Mary E.;
Corrigan, Derek;
Fahey, Tom;
Croker, Richard;
Bacon, Sebastian C. J.;
Inglesby, Peter;
Evans, David;
Goldacre, Ben;
MacKenna, Brian;
Moriarty, Frank

Publication type:

Article

Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2636, doi. 10.1111/bcp.15757

By:

Montastruc, Jean‐Louis

Publication type:

Article

Whole‐bowel irrigation should not be used routinely in poisoned patients.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2362, doi. 10.1111/bcp.15750

By:

Sandilands, Euan A.

Publication type:

Article

Letter to the editor concerning the article: 'Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA adverse event reporting system (FAERS)'.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2639, doi. 10.1111/bcp.15746

By:

Sinvhal, Ranjeeta;
Krueger, Whitney S.;
Kilpatrick, Ryan D.;
Coppola, Danielle

Publication type:

Article

Stability for 6 months and accuracy of a specific enteral caffeine base preparation for a multisite clinical trial.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2631, doi. 10.1111/bcp.15739

By:

Erickson, Grant;
McAnulty, Michael;
Powers, Chelsea;
Luong, Thu‐Lan;
Dobson, Nicole R.;
Hunt, Carl E.

Publication type:

Article

Dicloxacillin‐warfarin drug–drug interaction—A register‐based study and in vitro investigations in 3D spheroid primary human hepatocytes.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2614, doi. 10.1111/bcp.15738

By:

Järvinen, Erkka;
Dalgård Dunvald, Ann‐Cathrine;
Ernst, Martin Thomsen;
Hammer, Helen S.;
Pötz, Oliver;
Pottegård, Anton;
Stage, Tore B.

Publication type:

Article

The safe use of metformin in heart failure patients both with and without T2DM: A cross‐sectional and longitudinal study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2603, doi. 10.1111/bcp.15737

By:

Chowdhury, Gina;
Carland, Jane E.;
Kumar, Shaun;
Olsen, Nick;
Graham, Garry;
Kumarasinghe, Gayathri;
Hayward, Christopher S.;
Greenfield, Jerry R.;
Macdonald, Peter;
Day, Richard O.;
Stocker, Sophie L.

Publication type:

Article

Effect of CYP3A4 induction and inhibition on the pharmacokinetics of SHR0302 in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2561, doi. 10.1111/bcp.15733

By:

Zhang, Zhe;
Gao, Xuehu;
Zhang, Ping;
Li, Yuan;
Fu, Meng;
Lin, Hongda;
Feng, Sheng;
Shen, Kai;
Yu, Guoning;
Li, Xin

Publication type:

Article

Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2582, doi. 10.1111/bcp.15732

By:

Taagaard, Mille;
Rode, Line;
de Wolff, Mie Gaarskjær;
Damm, Peter;
Hagen, Casper P.;
Fisher, Margit Bistrup;
Hegaard, Hanne Kristine;
Rom, Ane Lilleøre

Publication type:

Article

Inconsistencies of absolute drug–drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2552, doi. 10.1111/bcp.15730

By:

Weisbach, Laura;
Schuster, Anna K.;
Hartmann, Michael;
Dürr, Pauline;
Then, Melanie I.;
Andrikyan, Wahram;
Fromm, Martin F.;
Maas, Renke;
Farker, Katrin

Publication type:

Article

Off‐label and unlicensed medicine prescribing in university hospital paediatric wards in Finland: A prospective study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2592, doi. 10.1111/bcp.15729

By:

Kaisto, Hanna;
Sepponen, Kati;
Lindell‐Osuagwu, Leena;
Sankilampi, Ulla

Publication type:

Article

Towards Optimizing Hospitalized Older adults' MEdications (TO HOME): Multi‐centre study of medication use and outcomes in routine care.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2508, doi. 10.1111/bcp.15727

By:

Hilmer, Sarah N.;
Lo, Sarita;
Kelly, Patrick J.;
Viney, Rosalie;
Blyth, Fiona M.;
Le Couteur, David G.;
McLachlan, Andrew J.;
Arora, Sheena;
Hossain, Lutfun;
Gnjidic, Danijela

Publication type:

Article

Effect of esketamine on opioid consumption and postoperative pain in thyroidectomy: A randomized controlled trial.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2542, doi. 10.1111/bcp.15726

By:

Wang, Penglei;
Song, Meixian;
Wang, Xiaoli;
Zhang, Ye;
Wu, Yun

Publication type:

Article

Initiation of glucose‐lowering drugs reduces the anticoagulant effect of warfarin—But not through altered drug metabolism in patients with type 2 diabetes.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2529, doi. 10.1111/bcp.15725

By:

Dunvald, Ann‐Cathrine Dalgård;
Nielsen, Flemming;
Olsen, Dorte Aalund;
Ernst, Martin Thomsen;
Donnelly, Louise;
Soto‐Pedre, Enrique;
Kristiansen, Maja Refshauge;
Nielsen, Jens Steen;
Persson, Frederik;
Højlund, Kurt;
Madsen, Jonna Skov;
Søndergaard, Jens;
Pearson, Ewan;
Pottegård, Anton;
Stage, Tore Bjerregaard

Publication type:

Article

Evaluation of diagnostic and prognostic candidate biomarkers in drug‐induced liver injury vs. other forms of acute liver damage.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2497, doi. 10.1111/bcp.15724

By:

Cueto‐Sánchez, Alejandro;
Niu, Hao;
Álvarez‐Álvarez, Ismael;
López‐Longarela, Bárbara;
Del Campo‐Herrera, Enrique;
Ortega‐Alonso, Aida;
García‐Cortés, Miren;
Pinazo‐Bandera, José;
Sanabria‐Cabrera, Judith;
Díaz‐Mochón, Juan José;
Lucena, M. Isabel;
Andrade, Raúl J.;
Stephens, Camilla;
Robles‐Díaz, Mercedes

Publication type:

Article

Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2458, doi. 10.1111/bcp.15720

By:

Breithaupt, Mareile H.;
Krohmer, Evelyn;
Taylor, Lenka;
Körner, Eva;
Hoppe‐Tichy, Torsten;
Burhenne, Juergen;
Foerster, Kathrin I.;
Dachtler, Markus;
Huber, Gerald;
Venkatesh, Rakesh;
Eggenreich, Karin;
Czock, David;
Mikus, Gerd;
Blank, Antje;
Haefeli, Walter E.

Publication type:

Article

Physiologically based pharmacokinetic and pharmacodynamic modelling of alprazolam: Implications for anxiety and addiction.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2569, doi. 10.1111/bcp.15719

By:

Burkat, Paul M.

Publication type:

Article

Concomitant use of statins and sodium‐glucose co‐transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2430, doi. 10.1111/bcp.15711

By:

Gravel, Christopher A.;
Krewski, Daniel;
Mattison, Donald R.;
Momoli, Franco;
Douros, Antonios

Publication type:

Article

Comparative validation of HAS‐BLED, GARFIELD‐AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL‐AF registry.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2472, doi. 10.1111/bcp.15716

By:

Chichareon, Ply;
Winijkul, Arjbordin;
Lip, Gregory Y. H.;
Krittayaphong, Rungroj

Publication type:

Article

Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the explanatory factors?

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2446, doi. 10.1111/bcp.15715

By:

Arrivé, Capucine;
Fonrose, Xavier;
Thomas, Fabienne;
Roth, Gaël;
Jacquet, Emmanuelle;
Brice, Aurélie;
Chirica, Carole;
Farneti, Delphine;
Frenoux, Coralie;
Stanke‐Labesque, Françoise;
Gautier‐Veyret, Elodie

Publication type:

Article

Treatment with methylphenidate and the risk of fractures among children and young people: A systematic review and self‐controlled case series study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2519, doi. 10.1111/bcp.15714

By:

Gao, Le;
Man, Kenneth K. C.;
Fan, Min;
Ge, Grace M. Q.;
Lau, Wallis C. Y.;
Cheung, Ching‐Lung;
Coghill, David;
Ip, Patrick;
Wong, Kirstie H. T. W.;
Wong, Ian C. K.

Publication type:

Article

CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone‐to‐renin ratio, an indicator of sodium retention, in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2483, doi. 10.1111/bcp.15713

By:

Mulatero, Paolo;
Groessl, Michael;
Vogt, Bruno;
Schumacher, Christoph;
Steele, Ronald Edward;
Brooks, Ashley;
Hossack, Stuart;
Brunner, Hans‐Rudolf

Publication type:

Article

Procedural sedation for paediatric patients with spinal muscular atrophy undergoing intrathecal treatment.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2465, doi. 10.1111/bcp.15718

By:

Sever, Feyza;
Özmert, Sengül;
Arıbaş Öz, Nefise

Publication type:

Article

Evidence of potential pro‐haemorrhagic drug interactions between CYP3A4 inhibitors and direct oral anticoagulants: Analysis of the FAERS database.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2423, doi. 10.1111/bcp.15710

By:

Li, Dandan;
Yan, Cilin;
Guo, Mingxing;
Zhao, Ying;
Zhang, Yang;
Cui, Xiangli

Publication type:

Article

Post‐percutaneous coronary intervention CYP2C19 genotyping in an Irish population: The potential role in identifying clopidogrel therapy‐related bleeding risks.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2413, doi. 10.1111/bcp.15709

By:

Soh, Bing Wei Thaddeus;
Cusack, Ronan;
Waters, Max;
O'Connor, Cormac;
Arnous, Samer;
Kiernan, Thomas

Publication type:

Article

Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2407, doi. 10.1111/bcp.15704

By:

Um, Sung Ho;
Abuzgaia, Awatif;
Rieder, Michael

Publication type:

Article

Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2396, doi. 10.1111/bcp.15703

By:

Procaccini, David E.;
Roem, Jennifer;
Ng, Derek K.;
Rappold, Thomas E.;
Jung, Dawoon;
Gobburu, Jogarao V. S.;
Bembea, Melania M.

Publication type:

Article

The role of whole bowel irrigation in the treatment of toxic ingestions.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2359, doi. 10.1111/bcp.15652

By:

Tenenbein, Milton

Publication type:

Article

Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS).

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2386, doi. 10.1111/bcp.15581

By:

Woods, Richard H.

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2023, v. 89, n. 8, p. 2335, doi. 10.1111/bcp.15403
Publication type:: Article